Clairity Breast, an image-based artificial intelligence platform that can help clinicians predict five-year breast cancer risk based solely on a routine mammogram, is now the first such breast cancer ...

Combining standard adjuvant chemotherapy with the immune checkpoint inhibitor atezolizumab [Tecentriq] leads to a significant improvement in disease-free survival in a subset of patients with Stage ...

People who are overweight or obese are at higher risk for at least 13 different types of cancer, which together make up about 40 percent of all cancer diagnoses in the United States, according to the ...

Results from the Phase III SERENA-6 clinical trial found that switching to treatment with camizestrant if an ESR1 mutation is detected during first-line treatment can help slow cancer growth for ...

A new study by researchers at the American Cancer Society (ACS) shows Medicaid expansion was associated with an increase in Medicaid coverage, early-stage cancer diagnoses, and improved two-year ...

Kelly Bolton St. Louis, Missouri To help prevent blood cancers, Kelly Bolton, MD, PhD, an oncologist and epidemiologist at the University of Washington Medical School, is leading clinical trials for ...

A pre-surgical combination therapy including pembrolizumab [Keytruda] plus dabrafenib [Tafinlar] and trametinib [Mekinist] (DTP) significantly improved survival in patients with rare BRAF ...

Chemotherapy doesn’t just kill cancer cells. It also affects the microbes in the digestive tract. Researchers at UC San Francisco have discovered that some gut bacteria can reduce the side effects of ...

The number of people living with a history of cancer in the United States is estimated at 18.6 million as of January 1, 2025 and projected to exceed 22 million by 2035, according to a new report, ...

Here's a list of the approved drugs to treat colon cancer, also known as colorectal cancer. Click on any of the medications for more info on indications, dosing and side effects. Keytruda is a PD-1 ...

People who used GLP-1 receptor agonists, like Ozempic, had a modestly lower risk for obesity-related malignancies, especially colon and rectal cancer.

Bruce Wright, 79, who lives with his wife in Ladera Ranch, California, discovered in 2009 that he had both chronic lymphocytic leukemia (CLL) and prostate cancer.